Novo Nordisk A/S (NVO)
49.33
+2.97
(+6.41%)
USD |
NYSE |
Dec 10, 15:06
Novo Nordisk Market Cap: 219.20B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 41.03M |
| Ascendis Pharma A/S | 12.20B |
| Regeneron Pharmaceuticals, Inc. | 75.73B |
| Omeros Corp. | 820.32M |
| Viking Therapeutics, Inc. | 4.243B |
Market Cap Related Metrics
| PE Ratio | 14.37 |
| PS Ratio | 4.706 |
| PEG Ratio | 1.269 |
| Price to Book Value | 10.81 |
| Price to Free Cash Flow | 23.77 |
| Price | 49.33 |
| Earnings Yield | 6.96% |
| PEGY Ratio | 0.9550 |
| Operating PE Ratio | 11.10 |
| Normalized PE Ratio | 14.37 |